Kawaguchi Y - Search Results

1

Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.

Kurokawa N, Robinson MK, Bernard C, Kawaguchi Y, Koujin Y, Koen A, Madhi S, Polasek TM, McNeal M, Dargis M, Couture MM, Trépanier S, Forrest BD, Tsutsui N. Kurokawa N, et al. Among authors: kawaguchi y. Vaccine. 2021 Sep 15;39(39):5513-5523. doi: 10.1016/j.vaccine.2021.08.052. Epub 2021 Aug 25. Vaccine. 2021. PMID: 34454786 Clinical Trial.

2

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study.

Nangaku M, Kondo K, Ueta K, Kokado Y, Kaneko G, Matsuda H, Kawaguchi Y, Komatsu Y. Nangaku M, et al. Among authors: kawaguchi y. Nephrol Dial Transplant. 2021 Aug 27;36(9):1731-1741. doi: 10.1093/ndt/gfab055. Nephrol Dial Transplant. 2021. PMID: 33650630 Free PMC article. Clinical Trial.

3

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima S, Maruyama N, Kawaguchi Y, Goda M, Iijima H. Inagaki N, et al. Among authors: kawaguchi y. Cardiovasc Diabetol. 2016 Jun 18;15:89. doi: 10.1186/s12933-016-0407-4. Cardiovasc Diabetol. 2016. PMID: 27316668 Free PMC article. Clinical Trial.

4

Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima SI, Kaku K, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Iijima H. Inagaki N, et al. Among authors: kawaguchi y. Diabetes Obes Metab. 2018 Apr;20(4):812-820. doi: 10.1111/dom.13152. Epub 2017 Dec 5. Diabetes Obes Metab. 2018. PMID: 29110384 Free PMC article. Clinical Trial.

5

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.

Nangaku M, Kondo K, Kokado Y, Ueta K, Kaneko G, Tandai T, Kawaguchi Y, Komatsu Y. Nangaku M, et al. Among authors: kawaguchi y. J Am Soc Nephrol. 2021 Jul;32(7):1779-1790. doi: 10.1681/ASN.2020091311. Epub 2021 Apr 21. J Am Soc Nephrol. 2021. PMID: 33883252 Free PMC article.

6

A phase 3, open-label, single-arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis-stimulating agents.

Nangaku M, Kondo K, Takabe S, Ueta K, Tandai T, Kawaguchi Y, Komatsu Y. Nangaku M, et al. Among authors: kawaguchi y. Ther Apher Dial. 2022 Feb;26(1):45-54. doi: 10.1111/1744-9987.13699. Epub 2021 Jun 28. Ther Apher Dial. 2022. PMID: 34115437 Free PMC article. Clinical Trial.

7

Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial.

Wada T, Mori-Anai K, Kawaguchi Y, Katsumata H, Tsuda H, Iida M, Arakawa K, Jardine MJ. Wada T, et al. Among authors: kawaguchi y. J Diabetes Investig. 2022 Jan;13(1):54-64. doi: 10.1111/jdi.13624. Epub 2021 Aug 3. J Diabetes Investig. 2022. PMID: 34212533 Free PMC article. Clinical Trial.

8

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open-label study in Japan.

Nangaku M, Kondo K, Takabe S, Ueta K, Kaneko G, Otsuka M, Kawaguchi Y, Komatsu Y. Nangaku M, et al. Among authors: kawaguchi y. Ther Apher Dial. 2021 Oct;25(5):642-653. doi: 10.1111/1744-9987.13611. Epub 2020 Dec 29. Ther Apher Dial. 2021. PMID: 33283981 Free PMC article. Clinical Trial.

9

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study.

Harashima SI, Inagaki N, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Watanabe Y. Harashima SI, et al. Among authors: kawaguchi y. Diabetes Obes Metab. 2018 Jul;20(7):1770-1775. doi: 10.1111/dom.13267. Epub 2018 Mar 24. Diabetes Obes Metab. 2018. PMID: 29473709 Free PMC article. Clinical Trial.

10

Changes in and clinical utility of maximum phonation time and repetitive saliva swallowing test scores after esophagectomy.

Maruyama S, Kawaguchi Y, Nitta K, Akaike H, Shoda K, Higuchi Y, Nakayama T, Saito R, Izumo W, Takiguchi K, Shiraishi K, Furuya S, Nakata Y, Amemiya H, Kawaida H, Ichikawa D. Maruyama S, et al. Among authors: kawaguchi y. Esophagus. 2024 May 24. doi: 10.1007/s10388-024-01065-9. Online ahead of print. Esophagus. 2024. PMID: 38787481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,679 results

Search Page